WT1 peptide vaccine stabilized intractable ovarian cancer patient for one year: A case report

Anticancer Research

Volumn 31, Issue 7, 2011, Pages 2441-2446

  Dohi, Satoshi ^a   Ohno, Satoshi ^a,b   Ohno, Yumiko ^a   Takakura, Masahiro ^a   Kyo, Satoru ^a   Soma, Gen Ichiro ^c,d   Sugiyama, Haruo ^e   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Immunotherapy; Ovarian cancer; WT1 peptide vaccine

Indexed keywords

CARBOPLATIN; DOCETAXEL; PACLITAXEL; TUMOR MARKER; WT1 PROTEIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CARCINOMA CELL; CASE REPORT; FEMALE; HUMAN; NEPHROBLASTOMA; OVARY CANCER; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; CA-125 ANTIGEN; CANCER VACCINES; CARBOPLATIN; CLINICAL TRIALS, PHASE II AS TOPIC; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; FEMALE; HLA-A ANTIGENS; HUMANS; IMMUNOTHERAPY, ACTIVE; MEMBRANE PROTEINS; MIDDLE AGED; OMENTUM; OVARIAN NEOPLASMS; PACLITAXEL; PEPTIDE FRAGMENTS; PERITONEAL NEOPLASMS; TAXOIDS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; VACCINES, SUBUNIT; WT1 PROTEINS;

EID: 79961175455     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C and Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990.
2. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH and Bruns GA: Homozygous deletion in Wilms tumors of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778, 1990.
3. Rivera MN and Haber DA: Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5: 699-712, 2005. (Pubitemid 41486363)
4. Sugiyama H: Wilms' tumor gene WT1: its oncogenic function and clinical application. Int J Hematol 73: 177-187, 2001.
5. Oka Y, Tsuboi A, Kawakami M, Elisseeva OA, Nakajima H, Udaka K, Kawase I, Oji Y and Sugiyama H: Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers. Curr Med Chem 13: 2345-2352, 2006. (Pubitemid 44184641)
6. Yang L, Han Y, Suarez Saiz F and Minden MD: A tumor suppressor and oncogene: the WT1 story. Leukemia 21: 868-876, 2007. (Pubitemid 46672061)
7. Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, Kawano K, Kuwae Y, Yamauchi A, Okamura M, Kitamura Y, Oka Y, Kawase I, Sugiyama H and Aozasa K: Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 19: 804-814, 2006. (Pubitemid 43780450)
8. Ohno S, Dohi S, Ohno Y, Kyo S, Sugiyama H, Suzuki N and Inoue M: Immunohistochemical detection of WT1 protein in endometrial cancer. Anticancer Res 29: 1691-1695, 2009.
9. Oka Y, Tsuboi A, Murakami M, Hirai M, Tominaga N, Nakajima H, Elisseeva OA, Masuda T, Nakano A, Kawakami M, Oji Y, Ikegame K, Hosen N, Udaka K, Yasukawa M, Ogawa H, Kawase I and Sugiyama H: Wilms' tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. Int J Hematol 78: 56-61, 2003. (Pubitemid 36899903)
10. Tsuboi A, Oka Y, Osaki T, Kumagai T, Tachibana I, Hayashi S, Murakami M, Nakajima H, Elisseeva OA, Fei W, Masuda T, Yasukawa M, Oji Y, Kawakami M, Hosen N, Ikegame K, Yoshihara S, Udaka K, Nakatsuka S, Aozasa K, Kawase I and Sugiyama H: WT1 peptide-based immunotherapy for patients with lung cancer: Report of two cases. Microbial Immunol 48: 175-184, 2004. (Pubitemid 38405079)
11. Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H, Elisseeva OA, Oji Y, Kawakami M, Ikegame K, Hosen N, Yoshihara S, Wu F, Fujiki F, Murakami M, Masuda T, Nishida S, Shirakata T, Nakatsuka S, Sasaki A, Udaka K, Dohy H, Aozasa K, Noguchi S, Kawase I and Sugiyama H: Induction of WT1 (Wilms' tumor gene) - specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 101: 13885-13890, 2004. (Pubitemid 39298502)
12. Izumoto S, Tsuboi A, Oka Y, Suzuki T, Hashiba T, Kagawa N, Hashimoto N, Maruno M, Elisseeva OA, Shirakata T, Kawakami M, Oji Y, Nishida S, Ohno S, Kawase I, Hatazawa J, Nakatsuka S, Aozasa K, Morita S, Sakamoto J, Sugiyama H and Yoshimine T: Phase II clinical trial of Wilms' tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme. J Neurosurg 108: 963-971, 2008. (Pubitemid 351656845)
13. Ohno S, Kyo S, Myojo S, Dohi S, Ishizaki J, Miyamoto K, Morita S, Sakamoto J, Enomoto T, Kimura T, Oka Y, Tsuboi A, Sugiyama H and Inoue M: Wilms' tumor 1 (WT1) peptide immunotherapy for gynecological malignancy. Anticancer Res 29: 4779-4784, 2009.
14. Maeda H, Matsuzaki K, Miura O, Kawano T, Toda T, Minamisono Y, Nagasaki S and Ogoshi S: Quantitative alterations of peripheral monocytes and lymphocytes in patients with gastric cancer. Jpn J Cancer Clin 44(8): 799-803, 1998.
15. Belli F, Testori A, Rivoltini L, Maio M, Andreola G, sertoli MR, Gallino G, Piris A, Cattelan A, Lazzari I, Carrabba M, Scita G, Santantonio C, Pilla L, Tragni G, Lombardo C, Arienti F, Marchiano A, Queriolo P, Bertolini F, Cova A, Lamaj E, Ascani L, Camerini R, Corsi M, Cascinelli N, Lewis JJ, Srivastava P and Parmiani G: Vaccination of metastatic melanoma patients with autologous tumor-derived heat-shock protein GP96-peptide complexes: clinical and immunologic findings. J Clin Oncol 20(20): 4169-4180, 2002.
16. Bolonaki I, Kotsakis A, Papadimitraki E, Aggouraki D, Konsolakis G, Vagia A, Christophylakis C, Nikoloudi I, Magganas E, Galanis A, Cordopatis P, Kosmatopoulos K, Georgoulias V and Mavroudis D: Vaccination of patients with advanced non-small cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide. J Clin Oncol 25(19): 2727-2734, 2007. (Pubitemid 47123180)
17. Ohta H, Yoneda A, Takizawa S, Fukuzawa M, Tsuboi A, Murao A, Oji Y, Aozasa K, Nakatsuka S, Sugiyama H and Ozono K: WT1 (Wilms' tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report. Pediatr Hematol Oncol 26: 74-83, 2009.